Home > Products > CD19 & CD22
> Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG-scFv)
Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG-scFv) (CAT#: IGFV-039)
Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb is designed for the research of B cell lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG-scFv) (IGFV-039). Click the button below to contact us or submit your feedback about this product.